Cyclobenzaprine hydrochloride for stress disorders, traumatic, acute

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Oct 2024: Trial registered, NCT06636786
  2. 25 Mar 2025: Trial started, NCT06636786

The trials

NCT06636786: Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

State
Under way
Phase
Phase 2
People
180 planned
Started
25 Mar 2025
Primary completion
Nov 2026
Arms
Cyclobenzaprine HCl
Results
None posted
  1. 15 Oct 2024: Trial registered
  2. 25 Mar 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Amrix, Cyclobenzaprine HCl, Flexeril, Tonmya.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.